# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Outset Medical (NASDAQ:OM) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.55...
Outset said that it has resumed distribution of TabloCart with prefiltration and has product available to ship to customers in ...
Agreement designed to provide patients and caregivers access to innovative home dialysis with the Tablo® Hemodialysis System
Shares of Agenus Inc. (NASDAQ: AGEN) fell sharply during Monday’s session. Agenus disclosed a 1-for-20 reverse stock split of ...